JPRN-UMIN000030732尚未招募未知
Randomized Evaluation of Sirolimus-eluting versus Everolimus-eluting Stent Trial: Extended Follow-up Study - RESET:Extended Follow-up Study
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 3,196
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who refuse to participate.
研究者
相似试验
进行中（未招募）
1 期
on-randomised Open Label Pilot Study of Sirolimus Therapy for Segmental Overgrowth Due to PIK3CA- Related OvergrowthEUCTR2014-005320-10-FRCHU de DIJO
进行中（未招募）
1 期
Prospective comparison of sirolimus against corticosteroids in treatment of patients with active thyroid eye diseaseThyroid eye diseaseCTIS2023-510166-27-01Helse Bergen HF70
已完成
不适用
Ten-Year Outcomes of PRE-COMBAT TrialCoronary Artery DiseaseNCT03871127Seung-Jung Park600
进行中（未招募）
1 期
Sirolimus vs Corticosteroids in Treatment of Thyroid Eye DiseaseThyroid Eye Disease (TED) in patients with Graves' Diease.EUCTR2021-000641-41-NOHelse Bergen HF, Haukeland University Hospital70
已完成
4 期
Randomized Evaluation of Sirolimus-eluting Versus Everolimus-eluting Stent TrialCoronary Artery DiseaseNCT01035450Takeshi Morimoto3,206